Clinical Trial Update: Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating imaging, clinical and biochemical biomarkers for Parkinson's disease and Parkinsonian syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonian Syndrome

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Parkinson's Disease, Parkinsonian Syndrome | Phase 2 | Status: COMPLETED